https://doi.org/10.4081/hmr.v2i7.395

Nuclear medicine perspective on radioimmunotherap

Vol. 2 No. 7: New Insights in Hematology, Venice (Italy), May 14-17, 2006
Published: June 8, 2009
Abstract Views: 359
PDF: 257
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

S Fanti
support@pagepress.org
G Montini
M Farsad
Radioimmunotherapy is a new type of therapy that targets radiation to the tumor using monoclonal antibodies (MAbs). The use of radiolabeled MAbs as a potential cancer treatment was first explored in the ‘50s. Only in the ‘70s, however, technological advancements allowed for the design and production of monoclonal antibodies directed against specific cellular antigens. The feasibility of combining a monoclonal antibodies directed against specific tumor-associated antigens with a radioisotope in order to deliver a therapeutic dose of radiation to a tumor cell has been studied since the early ‘80s.

Dimensions

Altmetric

PlumX Metrics

Downloads

Citations

Crossref
Scopus
Google Scholar
Europe PMC

Supporting Agencies

How to Cite

Fanti, S., Montini, G., & Farsad, M. (2009). Nuclear medicine perspective on radioimmunotherap. Hematology Meeting Reports (formerly Haematologica Reports), 2(7). https://doi.org/10.4081/hmr.v2i7.395
Authors who publish with this journal agree to the following terms: Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).